News and Updates

Playboy: Massive National Drug Deal Set to Take Place (for a Good Cause)

April 11, 2016

Summary: Playboy reports on MAPS' Global Psychedelic Dinners, a worldwide fundraising initiative to purchase one kilogram of pharmaceutical-grade MDMA for Phase 3 trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). The article highlights MAPS as one of the leading organizations working towards reducing the stigma surrounding psychedelics by promoting and funding ongoing psychedelic research."Psychedelics are becoming less of a countercultural term and more of a medical or spiritual one,” explains MAPS Director of Communications and Marketing Brad Burge. Read more...


Global Psychedelic Dinners: Host Information

March 24, 2016

We are now sending out the first round of Host Packages for the Global Psychedelic Dinners! Host Packs are filled with everything you need to host your Global Psychedelic Dinner, including the Official Host Guide, dinner ideas, tips, and fundraising materials such as stickers, pledge cards, and a donation box to use at your event. Request your Host Pack...


The Future of Therapy Involves a Little Bit of MDMA

March, 24, 2016

Mic outlines the future of psychedelic research, detailing MAPS' current clinical trials into MDMA-assisted psychotherapy for a variety of mental health issues. Ruth Reader of Mic highlights MAPS' Global Psychedelic Dinners initiative, stating, "MAPS has just purchased $400,000 worth of MDMA for its phase 3 trials. To pay for the bulk purchase, the organization is hosting a series of dinners." Read more...


Thump: A Nonprofit is Raising $400,000 for a Kilo of MDMA by Hosting "Psychedelic Dinner" Parties

March 1, 2016

Summary: Thump interviews Brad Burge of MAPS to discuss how MAPS' Global Psychedelic Dinners initiative is helping raise funds to buy one kilogram of pharmaceutical-grade MDMA and reduce stigma surrounding psychedelics. "Our goal is to have FDA approval for MDMA as a legal option drug to be used only with therapy by 2021," says Burge. Read more...


Want to Legalize Medical MDMA? Attend a 'Psychedelic Dinner'

February 18, 2016

Summary: U.S. News and World Report highlights the Global Psychedelic Dinners, detailing how people from around the world are coming together help MAPS raise funds for making MDMA-assisted psychotherapy a legal treatment for PTSD by 2021. "In order to conduct phase three trials, MAPS has initiated the purchase of 1 kilogram of pharmaceutical-grade MDMA for $400,000 – inspiring the psychedelic dinner fundraising push," reports Steven Nelson of U.S. News and World Report. Read more...


Your EDM: MAPS Wants You To Host A ‘Psychedelic Dinner’ To Help Legalize Medical MDMA

February 18, 2016

Your EDM features the Global Psychedelic Dinners, outlining MAPS' initiative to raise funds for the purchase of one kilogram of pharmaceutical grade MDMA for Phase 3 trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). "In addition to raising funds, MAPS spokesman Brad Burge says the dinners aim to reduce stigma about using psychedelic drugs, with MDMA not currently legal for medical use in any country," reports Matthew Meadow of Your EDM. Read more...


PRESS RELEASE: Global Psychedelic Dinners Bring Communities Together to Make MDMA a Legal Medicine

MAPS celebrates three decades of advancements with worldwide benefit events to raise $400,000 for MDMA research

February 17, 2016

OAKLAND, CALIF. – This April, the Multidisciplinary Association for Psychedelic Studies (MAPS) celebrates 30 years of pioneering non-profit research and public education with the Global Psychedelic Dinners and 30th Anniversary Banquet and Celebration on April 17 at the Scottish Rite Center in Oakland, Calif.

These worldwide community-supported benefit events will support MAPS’ $400,000 purchase of one kilogram of MDMA manufactured under current Good Manufacturing Practices (cGMP) to be used in MAPS’ Phase 3 clinical trials of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) and other MDMA research worldwide.

Taking place throughout April, the Global Psychedelic Dinners are a way for people around the world to gather their community, host an open conversation about psychedelics and psychedelic experiences, and help raise funds to help make psychedelic therapy a legal treatment. Local hosts will plan their dinners; promote their dinners via personalized online fundraising pages; and ask their friends, family, and colleagues to donate in support of psychedelic psychotherapy research.

Starting today, the first $33,000 in donations to the Global Psychedelic Dinners will be doubled, thanks to a community challenge gift from Steve Chapman ($18,000), René and Susan Ruiz ($10,000), and Carey and Claudia Turnbull ($5,000). Donations must be made through the Global Psychedelic Dinners Razoo fundraiser page to be matched.

Since the Global Psychedelic Dinners launched on February 2, over 124 people in 19 countries have registered to host their own dinner. Over 34 people have joined the Global Psychedelic Dinners team on Razoo.

“The Global Psychedelic Dinners give people around the world a chance to help legalize psychedelic therapy by growing their own local communities, sharing their stories of what psychedelics mean to them, and raising funds for MAPS’ research,” says Brad Burge, Director of Communications and Marketing for MAPS. “It’s equal parts social movement, peer-to-peer fundraising, and community health advocacy. In addition to funding vital medical research, it’s also helping ignite conversations and raise awareness about the profound healing potential of psychedelic therapy.”

MAPS’ 30th Anniversary and Celebration will take place on April 17 at the historic Scottish Rite Center in Oakland, Calif. The Banquet includes an exquisite buffet dinner, a virtuoso cello performance by Cello Joe, and benefit addresses from leading psychedelic researchers, participants in MAPS-sponsored trials, philanthropists, acclaimed visionary artists Alex and Allyson Grey, and others.

The Celebration begins after dinner with a keynote address from MAPS Founder and Executive Director Rick Doblin, Ph.D., and continues into the night with a multimedia performance from internationally renowned artist Android Jones and Phadroid, a live performance of DJ Spooky’s “The Hidden Code,” and more to be announced. A visionary art gallery and a silent auction featuring rare artifacts from the psychedelic research community will also benefit MAPS.

All donations and ticket sales for the Global Psychedelic Dinners and 30th Anniversary Banquet and Celebration support MAPS’ work to make psychedelic therapy a legal treatment.

Founded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Since its founding, MAPS has disbursed over $26 million for psychedelic therapy and medical marijuana research and education, all donated by individuals and family foundations.

MAPS has completed an international series of Phase 2 clinical trials of MDMA-assisted psychotherapy for PTSD, and is now preparing for the FDA meetings to plan the Phase 3 trials required to obtain U.S. Food and Drug Administration (FDA) approval, starting in 2017. MAPS anticipates FDA approval for MDMA-assisted psychotherapy for PTSD as early as 2021.

More information: psychedelicdinners.org
Sponsorship opportunities: psychedelicdinners.org/sponsorship
Event tickets: psychedelicdinners.org/banquet

Media passes available. Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. to inquire.

###


CONTACT:

Brad Burge
This email address is being protected from spambots. You need JavaScript enabled to view it.
831-429-6362 x103


Motherboard: How to Legally Buy a Kilo of Pure MDMA

November 23, 2015

Summary: Motherboard outlines the bureaucratic process for obtaining pharmaceutical grade MDMA for research by examining MAPS' ongoing clinical trials to make MDMA-assisted psychotherapy into an FDA-approved prescription medicine. "In MAPS’s trials, researchers dose PTSD patients with MDMA before guiding them through a psychotherapy session—they’ve found evidence the drug helps patients tap into the trauma at the core of their disorder without having to relive it in the same visceral, terrifying way they would if they were sober,” reports Kaleigh Rogers of Motherboard. Read more...

Share This Page